Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Treatment of Diabetic Macular Edema with Intravitreal Antivascular Endothelial Growth Factor and Prompt versus Deferred Focal Laser during Long-Term Follow-Up and Identification of Prognostic Retinal Markers.

Weingessel B, Miháltz K, Gleiss A, Sulzbacher F, Schütze C, Vécsei-Marlovits PV.

J Ophthalmol. 2018 Oct 1;2018:3082560. doi: 10.1155/2018/3082560. eCollection 2018.

2.

Decision-making for cataract surgery: Changes within 7 years.

Weingessel B, Wahl M, Huf W, Vécsei-Marlovits PV.

Acta Ophthalmol. 2018 Oct 3. doi: 10.1111/aos.13834. [Epub ahead of print] No abstract available.

PMID:
30284377
3.

Comparison of Two Toric IOLs with Different Haptic Design: Optical Quality after 1 Year.

Miháltz K, Lasta M, Burgmüller M, Vécsei-Marlovits PV, Weingessel B.

J Ophthalmol. 2018 Feb 11;2018:4064369. doi: 10.1155/2018/4064369. eCollection 2018.

4.

The Influence of Lunar Phases on Complications in Cataract Surgery: An Analysis of 16,965 Patients.

Faschinger EM, Vécsei-Marlovits PV, Rabensteiner DF, Weingessel B.

J Ophthalmol. 2017;2017:1946527. doi: 10.1155/2017/1946527. Epub 2017 Jul 16.

5.

[Evaluation of Postoperative Astigmatism Correction and Postoperative Rotational Stability of Two Toric Intraocular Lenses].

Grohlich M, Miháltz K, Lasta M, Weingessel B, Vécsei-Marlovits V.

Klin Monbl Augenheilkd. 2017 Jun;234(6):796-804. doi: 10.1055/s-0043-100656. Epub 2017 Apr 5. German.

PMID:
28380650
6.

Patients' maximum acceptable waiting time for cataract surgery: a comparison at two time-points 7 years apart.

Weingessel B, Wahl M, Vécsei-Marlovits PV.

Acta Ophthalmol. 2018 Feb;96(1):88-94. doi: 10.1111/aos.13439. Epub 2017 Mar 30.

PMID:
28371427
7.

More frequent requests for day-case cataract surgery : An impressive mind switch in the Austrian population within 7 years.

Weingessel B, Wahl M, Vécsei-Marlovits PV.

Wien Med Wochenschr. 2017 Oct;167(13-14):314-319. doi: 10.1007/s10354-017-0554-6. Epub 2017 Mar 29.

PMID:
28357522
8.

Short-term effect of aflibercept on visual acuity and central macular thickness in patients not responding to ranibizumab and bevacizumab.

Maksys S, Richter-Müksch S, Weingessel B, Vécsei-Marlovits PV.

Wien Klin Wochenschr. 2017 May;129(9-10):351-357. doi: 10.1007/s00508-016-1055-0. Epub 2016 Aug 22. Review.

PMID:
27550436
9.

Patient knowledge concerning age-related macular degeneration: an AMD questionnaire.

Burgmüller M, Cakmak N, Weingessel B, Vécsei C, Vécsei-Marlovits PV.

Wien Klin Wochenschr. 2017 May;129(9-10):345-350. doi: 10.1007/s00508-016-1044-3. Epub 2016 Jul 25.

PMID:
27457875
10.

Clinical risk management - a 3-year experience of team timeout in 18 081 ophthalmic patients.

Weingessel B, Haas M, Vécsei C, Vécsei-Marlovits PV.

Acta Ophthalmol. 2017 Mar;95(2):e89-e94. doi: 10.1111/aos.13155. Epub 2016 Jul 16.

11.

OCULAR WAVEFRONT ABERRATIONS AND OPTICAL QUALITY IN DIABETIC MACULAR EDEMA.

Miháltz K, Kovács I, Weingessel B, Vecsei-Marlovits PV.

Retina. 2016 Jan;36(1):28-36. doi: 10.1097/IAE.0000000000000646.

PMID:
26049619
12.

Predictors of 1-year visual outcome in OCT analysis comparing ranibizumab monotherapy versus combination therapy with PDT in exsudative age-related macular degeneration.

Weingessel B, Mihaltz K, Vécsei-Marlovits PV.

Wien Klin Wochenschr. 2016 Aug;128(15-16):560-5. doi: 10.1007/s00508-015-0772-0. Epub 2015 Mar 19.

PMID:
25787216
13.

Level of knowledge about glaucoma in Vienna.

Fabjani S, Richter-Müksch S, Cakmak N, Markstaller M, Weingessel B, Vécsei-Marlovits VP.

Wien Klin Wochenschr. 2015 Aug;127(15-16):612-8. doi: 10.1007/s00508-014-0687-1. Epub 2015 Jan 17.

PMID:
25595116
14.

Differences of frequency in administration of ranibizumab and bevacizumab in patients with neovascular AMD.

Scholler A, Richter-Mueksch S, Weingessel B, Vécsei-Marlovits PV.

Wien Klin Wochenschr. 2014 Jun;126(11-12):355-9. doi: 10.1007/s00508-014-0539-z. Epub 2014 Apr 3.

PMID:
24696051
15.

Acute anterior uveitis is associated with depression and reduction of general health.

Maca SM, Wagner J, Weingessel B, Vécsei-Marlovits PV, Gruber K, Schiesser AW.

Br J Ophthalmol. 2013 Mar;97(3):333-7. doi: 10.1136/bjophthalmol-2012-302304. Epub 2013 Jan 19.

PMID:
23335208
16.

The significance of early treatment of exudative age-related macular degeneration: 12 months' results.

Weingessel B, Hintermayer G, Maca SM, Rauch R, Vecsei-Marlovits PV.

Wien Klin Wochenschr. 2012 Nov;124(21-22):750-5. doi: 10.1007/s00508-012-0249-3. Epub 2012 Oct 24.

PMID:
23093324
17.

Comparison of posterior capsule opacification between a 1-piece and a 3-piece microincision intraocular lens.

Prinz A, Vecsei-Marlovits PV, Sonderhof D, Irsigler P, Findl O, Weingessel B.

Br J Ophthalmol. 2013 Jan;97(1):18-22. doi: 10.1136/bjophthalmol-2012-301899. Epub 2012 Sep 5.

PMID:
22952402
18.

Time to first treatment: The significance of early treatment of exudative age-related macular degeneration.

Rauch R, Weingessel B, Maca SM, Vecsei-Marlovits PV.

Retina. 2012 Jul;32(7):1260-4. doi: 10.1097/IAE.0b013e3182018df6.

PMID:
22186738
19.

The influence of cortical, nuclear, subcortical posterior, and mixed cataract on the results of microperimetry.

Richter-Mueksch S, Sacu S, Weingessel B, Vécsei-Marlovits VP, Schmidt-Erfurth U.

Eye (Lond). 2011 Oct;25(10):1317-21. doi: 10.1038/eye.2011.156. Epub 2011 Jul 8.

20.

Which factors influence patients' maximum acceptable waiting time for cataract surgery? - a questionnaire survey.

Weingessel B, Richter-Mueksch S, Vécsei-Marlovits PV.

Acta Ophthalmol. 2011 May;89(3):e231-6. doi: 10.1111/j.1755-3768.2010.01938.x.

Supplemental Content

Loading ...
Support Center